CLINDAMYCIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Clindamycin Hydrochloride patents expire, and when can generic versions of Clindamycin Hydrochloride launch?
Clindamycin Hydrochloride is a drug marketed by Aurobindo Pharma, Chartwell Molecular, Cosette, Epic Pharma Llc, Glenmark Pharms Ltd, Micro Labs, Mylan Pharms Inc, Sun Pharm Inds Ltd, Teva, Watson Labs, and Zydus Pharms Usa. and is included in twelve NDAs.
The generic ingredient in CLINDAMYCIN HYDROCHLORIDE is clindamycin hydrochloride. There are fifty-five drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the clindamycin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clindamycin Hydrochloride
A generic version of CLINDAMYCIN HYDROCHLORIDE was approved as clindamycin hydrochloride by COSETTE on September 20th, 1989.
Summary for CLINDAMYCIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 32 |
| Raw Ingredient (Bulk) Api Vendors: | 145 |
| Clinical Trials: | 224 |
| Patent Applications: | 2,293 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in CLINDAMYCIN HYDROCHLORIDE? | CLINDAMYCIN HYDROCHLORIDE excipients list |
| DailyMed Link: | CLINDAMYCIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CLINDAMYCIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Frieder Schaumburg | Phase 4 |
| Abdul El-Rabbany | Phase 4 |
| University Hospital, Limoges | Phase 2 |
Pharmacology for CLINDAMYCIN HYDROCHLORIDE
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CLINDAMYCIN HYDROCHLORIDE
US Patents and Regulatory Information for CLINDAMYCIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 065442-001 | Aug 26, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mylan Pharms Inc | CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 091225-003 | May 31, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 063083-002 | Mar 18, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Cosette | CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 063029-002 | Aug 5, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Chartwell Molecular | CLINDAMYCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 065243-003 | Aug 12, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
